Chronic pain and depression · blood tests

Chronic Pain and Depression: What Your Blood Work Can Show

Blood work can show the inflammation and insulin resistance that tie chronic pain and depression together: C-reactive protein, fasting glucose and A1c, and the triglyceride and HDL pair. It cannot diagnose depression, but it flags the people in whom inflammation, blood sugar and mood are moving together.

Being told your pain is probably stress sounds like a verdict on your mind. For a sizable share of people with low mood, it is also a finding in the blood that nobody drew.

Chronic pain and depression are usually handled in different offices, by different specialists, on different forms, even though inflammation and blood sugar tie them together. That split has a price: the mood gets a questionnaire, the pain gets a scan, and the blood markers that connect the two often never get drawn. That gap is the argument of You Cannot Separate the Mind from the Metabolism, the video for chapter 21 of The Pained Brain by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Dr. KrisJay Fucanan, MD. The focus here is a narrower question: what would a measurement show in a real person, and what does the usual workup leave out?

How common is depression in people with chronic pain?

In pooled studies of adults with chronic pain, 36.7 percent carried a diagnosis of major depression, ranging from 29.1 percent in osteoarthritis to 54.0 percent in fibromyalgia. Questionnaires find more: across 376 studies, 39.3 percent had clinically significant depressive symptoms. A screen is not a diagnosis, and neither figure means the pain is psychological. What they mean is that low mood shows up beside pain so often that overlooking it is an error of its own.

The trouble starts when a physician notices the mood and stops. Patients told their pain is mostly stress often hear that it is not real.

How does inflammation in the blood relate to depression?

Depression is not only a pattern of thought. In a measurable subgroup it is an inflammatory state. Across 24 studies, people with major depression carried higher levels of two inflammatory messengers, tumor necrosis factor and interleukin-6. In pooled data on C-reactive protein, a routine marker of inflammation, 27 percent of depressed patients sat above 3 milligrams per liter and 58 percent above 1, at 1.46 times the odds of low-grade inflammation seen in matched controls.

The other side of that finding matters just as much. Roughly three quarters of depressed patients stay below the higher line. A C-reactive protein result cannot tell anyone whether they are depressed, and a normal value does not rule depression out. What it can do is flag the people in whom inflammation and mood are moving together, which changes what is worth working on.

Is insulin resistance linked to depression?

Insulin resistance, the state in which the body needs more and more insulin to handle the same meal, runs alongside depression in both directions. People who started out depressed faced 1.60 times the risk of developing type 2 diabetes, and people with diabetes faced 1.15 times the risk of developing depression. In a Dutch cohort of 601 adults with no history of depression, followed for nine years, a higher triglyceride-to-HDL ratio predicted a first major depression at a hazard of 1.89, higher fasting glucose at 1.37, and slipping into prediabetes during the first two years at 2.66.

Weight shows the same two-way pattern, with odds ratios of 1.55 from obesity toward depression and 1.58 from depression toward obesity. Treatment sits inside the loop as well. Among 294,719 British adults, antidepressant use was linked to a higher rate of gaining 5 percent of body weight, 11.2 against 8.1 per 100 person-years. That is not a reason to refuse or stop a medication; that decision belongs to you and your physician. It is a reason to have weight and glucose recorded before treatment begins, so any change is seen rather than guessed.

How does metabolic health affect chronic pain?

In a United States midlife cohort of 781 people, about a quarter showed a metabolic pattern: higher fasting glucose, A1c, triglycerides and waist size, with lower HDL. Seven years later, people in that group were about twice as likely, at 2.00 and 2.03 times, to have pain disrupting daily life or pain in three or more places. The pattern did not predict whether pain existed at all. It predicted how far pain spread and how much of life it took over.

Procedures feel the same terrain. Across 346 patients treated in seven hospitals with injections or radiofrequency procedures, each point of depression score lowered the odds of success, and obesity shrank the relief. An injection can still be the right bridge. The body it lands in decides how far that bridge reaches.

The social layer feeds every part of this. Older adults who felt lonely were more likely to develop chronic pain over the next seven years, an odds ratio of 1.61, and in chronically lonely people 209 genes in white blood cells ran differently, tilted toward inflammation. An empty house belongs in the history next to the lab results.

What blood tests does a typical pain visit miss?

A typical pain visit records a pain score, reviews imaging and may include a mood questionnaire. Many never add the pieces that sit between mood and pain: C-reactive protein, fasting glucose and A1c, the triglyceride and HDL pair, and a measurement of how much of the body is fat. Without them, a person with a rising A1c and a moderate mood score gets two separate conversations instead of one plan.

Measura [Cardiometabolic and Autonomic Health Analysis] is a testing service. It measures; it does not diagnose depression or any other disease on its own, does not treat, and sends results to your physician. Three of its measurements fit the terrain described above:

• Laboratory panels, the route for metabolic and inflammatory blood markers, drawn and trended over time.
• Bioimpedance body composition, which separates fat mass from lean mass so a normal weight does not hide a metabolic problem.
• Heart rate variability, which reflects how the autonomic nervous system, the automatic side of the stress response, balances activation and recovery.

None of these replaces a depression screen done by a clinician. Sleep, which drives much of the loop, is assessed separately and is not a Measura test.

What to ask for, and what numbers can and cannot do

One honest limit belongs on the page. In 665 people with chronic pain in several body regions followed for six years, baseline stress-system, immune and autonomic measures did not predict who improved. The terrain forecasts who gets sick better than it forecasts who gets well. Measure to change something, then measure again.

Useful questions for your next appointment: What is my C-reactive protein? What are my fasting glucose, A1c and triglyceride-to-HDL ratio? If a medication is starting, when will weight and glucose be rechecked? Is isolation in my life being treated as a finding? Plans that reached more than one layer did better: when primary care patients with depression and musculoskeletal pain received combined antidepressant care and pain self-management, 26.0 percent improved in both, against 7.9 percent with usual care. A fuller list is at questions worth asking your doctor, the study-by-study evidence is in the book companion for chapter 21, and what happens when a plan goes home is covered in how to lower insulin resistance and track it. Physicians can read the screening version.

Frequently asked questions

Can chronic pain make you feel depressed?

Low mood shows up beside chronic pain so often that overlooking it is an error of its own. In pooled studies of adults with chronic pain, 36.7 percent carried a diagnosis of major depression, rising to 54.0 percent in fibromyalgia, and 39.3 percent had clinically significant depressive symptoms on questionnaires. None of that means the pain is psychological. Inflammation and blood sugar tie the two together.

What treatment helps both chronic pain and depression?

Plans that reach more than one layer do better. When primary care patients with depression and musculoskeletal pain received combined antidepressant care and pain self-management, 26.0 percent improved in both, against 7.9 percent with usual care. Measuring C-reactive protein, fasting glucose, A1c and the triglyceride-to-HDL ratio shows whether inflammation and blood sugar belong in the plan too. Treatment decisions belong to you and your physician.

Can a blood test show whether I am depressed?

No. Depression is diagnosed through a clinical conversation and validated questionnaires, not a lab value. Blood work can show whether inflammation or insulin resistance is present alongside low mood. In pooled studies, roughly a quarter of people with depression, 27 percent, showed a C-reactive protein over the 3 milligram line, so most did not. A result describes your terrain, not your mood. What a test result can and cannot tell you explains the difference.

Does inflammation cause depression, or does depression cause inflammation?

The evidence runs both ways. High interleukin-6 in childhood came years before depression in young adulthood, and negative thinking about pain tracked inflammatory rises in the laboratory. Observational studies cannot settle the direction for any one person. The practical point is that both sides can be measured and both can change. How chronic pain and metabolic health connect covers the wider picture.

Why would insulin resistance matter if I am being treated for pain?

Because the metabolic pattern predicted how far pain spread and how much it interfered with life seven years later, at about twice the relative risk. Insulin resistance also predicted a first episode of depression in adults who had never had one. It often appears in fasting glucose, A1c and lipids years before diabetes. What insulin resistance looks like before diabetes walks through the markers.

Should I stop an antidepressant if I am gaining weight?

Not on your own. Antidepressant use was linked to a higher rate of weight gain in a large British cohort, and for the right patient the medication is still the correct choice. The better step is to ask your physician to record weight, body composition and glucose at the start and recheck them on a schedule. Why body composition tells you more than BMI explains what that measurement adds.

What happens to my results after Measura testing?

Results go to the physician who ordered the testing, who interprets them alongside your history, your mood screening and your examination. Measura measures and reports; it does not diagnose depression or treat it. Repeating a measurement later shows whether changes in sleep, food, movement or medication moved the numbers. Understanding your results describes how a report is read.

References

• Aaron, R. V., Ravyts, S. G., Carnahan, N. D., Bhattiprolu, K., Harte, N., McCaulley, C. C., Vitalicia, L., Rogers, A. B., Wegener, S. T., & Dudeney, J. (2025). Prevalence of Depression and Anxiety Among Adults With Chronic Pain: A Systematic Review and Meta-Analysis. JAMA Network Open, 8(3), e250268. https://doi.org/10.1001/jamanetworkopen.2025.0268
• Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010). A meta-analysis of cytokines in major depression. Biol Psychiatry, 67(5), 446–57. https://doi.org/10.1016/j.biopsych.2009.09.033
• Osimo, E. F., Baxter, L. J., Lewis, G., Jones, P. B., & Khandaker, G. M. (2019). Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med, 49(12), 1958–1970. https://doi.org/10.1017/S0033291719001454
• Khandaker, G. M., Pearson, R. M., Zammit, S., Lewis, G., & Jones, P. B. (2014). Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry, 71(10), 1121–8. https://doi.org/10.1001/jamapsychiatry.2014.1332
• Watson, K. T., Simard, J. F., Henderson, V. W., Nutkiewicz, L., Lamers, F., Nasca, C., Rasgon, N., & Penninx, B. W. J. H. (2021). Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study. Am J Psychiatry, 178(10), 914–920. https://doi.org/10.1176/appi.ajp.2021.20101479
• Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008). Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care, 31(12), 2383–90. https://doi.org/10.2337/dc08-0985
• Gafoor, R., Booth, H. P., & Gulliford, M. C. (2018). Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ, 361, k1951. https://doi.org/10.1136/bmj.k1951
• Liang, Y., & Booker, C. (2024). Allostatic load and chronic pain: a prospective finding from the national survey of midlife development in the United States, 2004-2014. BMC Public Health, 24(1), 416. https://doi.org/10.1186/s12889-024-17888-1
• Cohen, S. P., Doshi, T. L., Kurihara, C., Reece, D., Dolomisiewicz, E., Phillips, C. R., Dawson, T., Jamison, D., Young, R., & Pasquina, P. F. (2021). Multicenter study evaluating factors associated with treatment outcome for low back pain injections. Regional Anesthesia and Pain Medicine, 47(2), 89–99. https://doi.org/10.1136/rapm-2021-103247
• Generaal, E., Vogelzangs, N., Macfarlane, G. J., Geenen, R., Smit, J. H., de Geus, E. J., Dekker, J., & Penninx, B. W. (2017). Biological Stress Systems, Adverse Life Events, and the Improvement of Chronic Multisite Musculoskeletal Pain Across a 6-Year Follow-Up. J Pain, 18(2), 155–165. https://doi.org/10.1016/j.jpain.2016.10.010

Related reading

• Nerve Pain After Knee Replacement: What Testing Can and Cannot Show
• How to Lower Insulin Resistance: What Moves It, and How to Tell
• Laboratory Panels

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, medical director of Measura. Last reviewed September 12, 2026.